Mereo BioPharma Group plc
("Mereo" or the "Company")
Notification of Director and PDMR Dealings
London, November 22, 2019 - Mereo BioPharma Group plc (AIM: MPH, NASDAQ: MREO), a clinical stage UK based biopharmaceutical company focused on rare diseases, received notification that on November 22, 2019, Anders Ekblom, non-executive Director of Mereo, purchased 10000 American Depositary Shares (ADS) at a price of USD2.54 per ADS.
On October 04, 2019, Alastair Mackinnon, Chief Medical Officer of Mereo, purchased 15169 Ordinary Shares at a price of GBP0.59 per share. On the same day, Alastair also purchased 365 American Depositary Shares (ADS) at a price of USD3.29 per ADS.
The below announcement and notification is made in accordance with the EU Market Abuse Regulation. The form required under the EU Market Abuse Regulation follows.
1 |
Details of the person discharging managerial responsibilities |
a) |
Name |
Anders Ekblom |
2 |
Reason for the notification |
a) |
Position/status |
non-executive Director |
b) |
Initial notification/ Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
Mereo BioPharma Group plc |
b) |
LEI |
213800U8JQHIJOS5AS09 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument and identification code |
AMERICAN DEPOSITARY SHARES (ADS) EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF £0.003 EACH |
b) |
Nature of the transaction |
PURCHASE |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
USD2.54 |
10000 |
|
d) |
Aggregated information: volume, Price |
Aggregated volume: 10000 Aggregated price: USD2.54 |
e) |
Date of the transaction |
2019-11-22 |
f) |
Place of the transaction |
XNMS |
1 |
Details of the person discharging managerial responsibilities |
a) |
Name |
Alastair Mackinnon |
2 |
Reason for the notification |
a) |
Position/status |
Chief Medical Officer |
b) |
Initial notification/ Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
Mereo BioPharma Group plc |
b) |
LEI |
213800U8JQHIJOS5AS09 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument and identification code |
MEREO BIOPHARMA GROUP PLC ORDINARY SHARES |
b) |
Nature of the transaction |
PURCHASE |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
GBP0.59 |
15169 |
|
d) |
Aggregated information: volume, Price |
Aggregated volume: 15169 Aggregated price: GBP0.592 |
e) |
Date of the transaction |
2019-10-04 |
f) |
Place of the transaction |
AIMX |
1 |
Details of the person discharging managerial responsibilities |
a) |
Name |
Alastair Mackinnon |
2 |
Reason for the notification |
a) |
Position/status |
Chief Medical Officer |
b) |
Initial notification/ Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
Mereo BioPharma Group plc |
b) |
LEI |
213800U8JQHIJOS5AS09 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument and identification code |
AMERICAN DEPOSITARY SHARE (ADS) EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF GBP0.003 EACH |
b) |
Nature of the transaction |
PURCHASE |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
USD3.29 |
365 |
|
d) |
Aggregated information: volume, Price |
Aggregated volume: 365 Aggregated price: USD3.29 |
e) |
Date of the transaction |
2019-10-04 |
f) |
Place of the transaction |
XNMS |